Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
about
MLK3 Signaling in Cancer InvasionMAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomasMEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells.Domain specificity of MAP3K family members, MLK and Tak1, for JNK signaling in DrosophilaKinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancerPharmacologic inhibition of MLK3 kinase activity blocks the in vitro migratory capacity of breast cancer cells but has no effect on breast cancer brain metastasis in a mouse xenograft modelMetastasis as a therapeutic target in prostate cancer: a conceptual framework.Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors.Dissecting the signaling pathways associated with the oncogenic activity of MLK3 P252H mutationHyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK.MAPK7 Regulates EMT Features and Modulates the Generation of CTCs.Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast CellsMinireview: Mouse Models of Rho GTPase Function in Mammary Gland Development, Tumorigenesis, and MetastasisTargeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosisMixed Lineage Kinase-c-Jun N-Terminal Kinase Axis: A Potential Therapeutic Target in Cancer.miR-139-5p is a regulator of metastatic pathways in breast cancer.MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells.Involvement of mixed lineage kinase 3 in cancer.MiR-139-5p: promising biomarker for cancer.Oncogenic signaling of MEK5-ERK5.PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.Interaction with the Paxillin LD1 Motif Relieves MEKK2 Auto-inhibition.MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells.Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity.Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer.Cancer biology: Enzyme meets a surprise target.MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.Discovery and characterization of an iminocoumarin scaffold as an inhibitor of MEKK2 (MAP3K2).Global Approaches to Understanding Protein Kinase Functions
P2860
Q26746892-EDCACABD-A0A6-42A8-942D-79F3BC63EE24Q28393224-2EF5ACBD-2F5B-4339-B60C-5248F4B43EC3Q30366227-65780383-2998-4A07-B1F6-C2B77DD45F45Q33779539-B7F2D1FC-B2C1-47F9-8C73-BB4D1DFA6273Q33917578-3009B5CD-AEF6-4BDC-B75D-229CDA1A258DQ34268838-910D6AEE-60F6-4BBA-BD19-38CD1C5B69ABQ34448162-479CB058-2537-46D3-91D1-36EDF1A34228Q34470378-B50F9292-CF35-4407-92D0-19CBDF24AAA9Q35120706-F17F65CF-352A-4F8F-B192-50E682D29740Q35533008-998AB32C-5D07-425C-8C08-4C71F255C229Q35560430-BEFF0C27-5CCB-4527-A76C-0248D7B2D668Q35993392-EADD2D2C-091F-4A17-9080-AA116E26003DQ36293295-0B7A5ED8-AD7D-49BF-8F9C-4E3DAD6ECB33Q36587317-177DA2A4-B0C5-40DD-8FC9-574BC65EEFC8Q36632432-02D831A9-3B3A-499B-9D89-3668A26DABC1Q37207651-1D95A5D9-BFB0-4C81-A26F-C524380DE34EQ37392541-B5B873DC-ECD2-4A84-9E23-4D7F9276B50EQ37448717-17E4473E-5043-4206-AEEB-215C84449B18Q37651604-83C0148C-7168-43BD-AA3A-BA16569B7D3AQ38102775-2A0508B9-ED90-4159-A173-21E846DDBD85Q38359431-5926E36E-4C0A-473B-BFE9-85CEA56ADCB5Q39116456-E859DB19-6C67-44F7-A69D-BFBF7EEF2C8FQ39125642-B7AA1601-9039-4F0A-A86B-B74548D4E33CQ40159273-E8995D3E-61BA-4750-A857-641A319D0CA3Q41072269-585E2CBC-0F2D-4752-B4F0-8DB45DA57238Q41342704-B463EF88-34EE-4B17-899D-E55DAA7DF86BQ41548598-9678D2FA-BDB6-450F-A4B4-B6C4648B9411Q41948499-402C1A85-F4FC-4014-95BF-A2D3C9B3B955Q46272315-80EFDC12-BBEC-4BD4-B2D6-F41C12F7A8A8Q47224547-809FF17B-194A-4A94-8AA5-63C64FC84AADQ57833109-C3C60C72-3062-416E-9A64-1B297A9433D1
P2860
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
@en
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
@nl
type
label
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
@en
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
@nl
prefLabel
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
@en
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
@nl
P2093
P2860
P356
P1433
P1476
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
@en
P2093
B D Cuevas
D A Granger
G L Johnson
H G Dohlman
K Nakamura
M R Cronan
N L Johnson
P2860
P2888
P304
P356
10.1038/ONC.2011.544
P407
P577
2011-12-05T00:00:00Z
P5875
P6179
1042213120